Oral retinoids. What should the prescriber known about their teratogenic hazards among women of child-bearing potential?
Mitchell
A A
AA
Slone Epidemiology Unit, School of Public Health, Boston University School of Medicine, Massachusetts.
D000014:Abnormalities, Drug-Induced / Q000453:epidemiology; D000328:Adult; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D015474:Isotretinoin / Q000009:adverse effects; D011247:Pregnancy; D012176:Retinoids / Q000009:adverse effects*; D013723:Teratogens; D014481:United States / Q000453:epidemiology; D014801:Vitamin A / Q000009:adverse effects
D012176:Retinoids; D013723:Teratogens; D014801:Vitamin A; D015474:Isotretinoin